Home › Funds › ALLEN OPERATIONS LLC › RXRX
ALLEN OPERATIONS LLC position in RXRX
RECURSION PHARMACEUTICALS IN · Health Care
ALLEN OPERATIONS LLC reported holding 217,657 shares of RXRX (RECURSION PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$899K, representing 0.09% of its reported portfolio and ranking #30 among its reported holdings. ALLEN OPERATIONS LLC has disclosed RXRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ALLEN OPERATIONS LLC's RXRX position evolved
ALLEN OPERATIONS LLC first disclosed a stake in RXRX in Q3 2023 at 217,657 shares (US$1.7M). The position peaked in Q1 2024 at 217,657 shares, worth US$2.2M. Across 13 filings, ALLEN OPERATIONS LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 217,657 shares valued at US$899K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 217.66K | $1.67M | New |
| Q4 2023 | 217.66K | $2.15M | Hold |
| Q1 2024 | 217.66K | $2.17M | Hold |
| Q2 2024 | 217.66K | $1.63M | Hold |
| Q3 2024 | 217.66K | $1.43M | Hold |
| Q4 2024 | 217.66K | $1.47M | Hold |
| Q1 2025 | 217.66K | $1.15M | Hold |
| Q2 2025 | 217.66K | $1.10M | Hold |
| Q3 2025 | 217.66K | $1.06M | Hold |
| Q4 2025 | 217.66K | $890.22K | Hold |
| Q1 2026 | 217.66K | $668.21K | Hold |
| Q2 2026 | 217.66K | $798.80K | Hold |
| Q3 2026 | 217.66K | $898.92K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RXRX and 13F data
RXRX (RECURSION PHARMACEUTICALS IN) is a Health Care company. 29 other funds we track also report a position in RXRX — the largest reported positions include ARK Invest (US$184.8M), SOFTBANK GROUP CORP. (US$50.0M), MIC Capital Management UK LLP (US$35.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RXRX
- ARK Invest 44.75M sh · $184.80M · Q3 2026
- SOFTBANK GROUP CORP. 13.64M sh · $50.05M · Q2 2026
- MIC Capital Management UK LLP 9.64M sh · $35.39M · Q2 2026
- Data Collective IV GP, LLC 5.94M sh · $21.80M · Q2 2026
- DCVC Opportunity Fund II GP, LLC 3.95M sh · $14.50M · Q2 2026
- IQ EQ FUND MANAGEMENT (IRELAND) Ltd 2.68M sh · $11.06M · Q3 2026
More on ALLEN OPERATIONS LLC
FAQ
How long has ALLEN OPERATIONS LLC held RXRX?
ALLEN OPERATIONS LLC has disclosed RXRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ALLEN OPERATIONS LLC's current position in RXRX?
As of Q3 2026, ALLEN OPERATIONS LLC holds 217.66K shares of RXRX (RECURSION PHARMACEUTICALS IN), valued at $898.92K, representing 0.09% of its reported portfolio and ranking #30.
Has ALLEN OPERATIONS LLC been buying or selling RXRX?
In the latest 13F filing (Q3 2026), ALLEN OPERATIONS LLC held unchanged its position in RXRX. The position peaked in Q1 2024 at 217.66K shares.
Which other funds hold RXRX?
Other major institutional holders of RXRX include ARK Invest, SOFTBANK GROUP CORP., MIC Capital Management UK LLP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.